BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23339006)

  • 1. Selected neuroendocrine tumour markers, growth factors and their receptors in typical and atypical bronchopulmonary carcinoids.
    Telega A; Kos-Kudła B; Foltyn W; Blicharz-Dorniak J; Rosiek V
    Endokrynol Pol; 2012; 63(6):477-82. PubMed ID: 23339006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.
    Matar S; Malczewska A; Oberg K; Bodei L; Aslanian H; Lewczuk-Myślicka A; Filosso PL; Suarez AL; Kolasińska-Ćwikła A; Roffinella M; Kos-Kudła B; Ćwikła JB; Drozdov IA; Kidd M; Modlin IM
    Neuroendocrinology; 2020; 110(3-4):185-197. PubMed ID: 30995665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of determining the serum concentrations of vascular endothelial growth factor (VEGF) and its soluble receptor type 2 (sVEGF-2) in the differential diagnosis of adrenal incidentalomas.
    Foltyn W; Strzelczyk J; Marek B; Kajdaniuk D; Siemińska L; Rosiek V; Kos-Kudła B
    Endokrynol Pol; 2012; 63(1):22-8. PubMed ID: 22378094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression.
    Filosso PL; Kidd M; Roffinella M; Lewczuk A; Chung KM; Kolasinska-Cwikla A; Cwikla J; Lowczak A; Doboszynska A; Malczewska A; Catalano M; Zunino V; Boita M; Arvat E; Cristofori R; Guerrera F; Oliaro A; Tesselaar M; Buikhuisen W; Kos-Kudla B; Papotti M; Bodei L; Drozdov I; Modlin I
    Eur J Cardiothorac Surg; 2018 Mar; 53(3):631-639. PubMed ID: 29145657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective treatment of a hormonally inactive carcinoid tumour with somatostatin analogues: application of serum chromogranin-A for clinical follow-up].
    Igaz P; Rácz K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(49):2343-6. PubMed ID: 18048114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factors, angiogenesis, and survival in human ileal enterochromaffin cell carcinoids.
    Besig S; Voland P; Baur DM; Perren A; Prinz C
    Neuroendocrinology; 2009; 90(4):402-15. PubMed ID: 19816005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of circulating angiogenic factors in patients operated on for localized malignant melanoma.
    Bolander A; Wagenius G; Larsson A; Brattström D; Ullenhag G; Hesselius P; Ekman S; Bergqvist M
    Anticancer Res; 2007; 27(5A):3211-7. PubMed ID: 17970063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site.
    Wang YC; Iezza G; Zuraek MB; Jablons DM; Theodore PR; Bergsland EK; Donner DB; Warren RS; Nakakura EK
    J Surg Res; 2010 Sep; 163(1):47-51. PubMed ID: 20599218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
    Donica H; Malecha-Jędraszek A; Strosławska E; Burska A; Szubstarski F
    Folia Histochem Cytobiol; 2010 Dec; 48(4):603-10. PubMed ID: 21478104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prealbumin in the diagnosis of bronchopulmonary carcinoid tumours.
    Suresh UR; Wilkes S; Hasleton PS
    J Clin Pathol; 1991 Jul; 44(7):573-5. PubMed ID: 1713221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
    García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
    Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L
    Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
    Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
    J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of bronchopulmonary carcinoid tumours.
    Breederveld RS; Meijer S; Thunnissen FB; Stam J
    Neth J Surg; 1989 Aug; 41(4):82-4. PubMed ID: 2779815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery.
    Jurczyńska J; Stepień T; Lawnicka H; Stepień H; Krupiński R; Kołomecki K; Kuzdak K; Komorowski J
    Endokrynol Pol; 2009; 60(1):9-13. PubMed ID: 19224499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchopulmonary carcinoid tumours].
    Rena O; Filosso PL; Ruffini E; Oliaro A
    Minerva Chir; 2002 Aug; 57(4):403-23. PubMed ID: 12145571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of pulmonary carcinoids - ten-year results].
    Vodicka J; Spidlen V; Klecka J; Simanek V; Safranek J; Mukensnabl P
    Zentralbl Chir; 2011 Dec; 136(6):598-603. PubMed ID: 21786224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.